AstraZeneca trial failure raises bigger questions about its portfolio
AstraZenecaWainua's failed final trial was never expected to have a major financial impact on the company. Most analysts estimate that…
AstraZenecaPLC
AstraZeneca shares fall 9% after heart drug trial falls short of target
Actions of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug failed to…
Lilly, Novo and Pfizer seek new weight loss drugs
Drug makers have only been introducing GLP-1 pills for a few months and are undergoing big changes to the way…
Shares of weight-loss drug makers plunge 25% as safety data spooks investors
Shares in weight-loss drug maker Zealand Pharma plunged as much as 26% on Monday after new data on its experimental…
AstraZeneca CEO says AI is changing drug development and helping increase chances of success
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop drugs faster and make smarter decisions throughout the research…
Bristol Myers Squibb turns to China's Hengrui to replace pipeline
One of the largest U.S. pharmaceutical companies said this week that it will partner with a Chinese drugmaker to test…
The reality of Trump's drug prices will be set in the next 18 months
NovartisThe CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and that…
The European pharmaceutical industry is in danger from Trump's policies and China's biotech boom
Boxes of medicines are seen on the shelves of Keencare pharmacy, a member of the Green Light Group, on September…
AstraZeneca shares rise after surprise lung disease trial win
AstraZenecaShares rose more than 3% after Britain's most valuable company said its experimental drug for lung diseases met its target…
More medications should be available over the counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over-the-counter” unless a drug is…